These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11220525)

  • 1. Expanding immuno-therapies for type 1 diabetes.
    Diabetes Obes Metab; 2000 Apr; 2(2):118. PubMed ID: 11220525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heat shock protein protects beta cells. Is it possible soon to vaccinate against diabetes?].
    MMW Fortschr Med; 2003 May; 145(22):53. PubMed ID: 12866282
    [No Abstract]   [Full Text] [Related]  

  • 3. Heat shock protein therapy fails to prevent diabetes in NOD mice.
    Bowman M; Atkinson MA
    Diabetologia; 2002 Sep; 45(9):1350-1. PubMed ID: 12242470
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing type I diabetes mellitus.
    Laron Z
    Isr Med Assoc J; 2004 Dec; 6(12):787. PubMed ID: 15609902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy of recent-onset type I diabetes mellitus].
    Assan R
    Ann Med Interne (Paris); 1985; 136(6):451-2. PubMed ID: 4083634
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 1 diabetes immunotherapy: is the glass half empty or half full?
    Herold KC; Bluestone JA
    Sci Transl Med; 2011 Aug; 3(95):95fs1. PubMed ID: 21832236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice.
    Szebeni A; Prohászka Z; Buzás E; Falus A; Kecskeméti V
    Inflamm Res; 2008 Apr; 57(4):178-82. PubMed ID: 18351435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice.
    Liang J; Aihua Z; Yu W; Jingjing L
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):541-8. PubMed ID: 18473288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New prospects for immunotherapy at diagnosis of type 1 diabetes.
    Pozzilli P; Leslie RD
    Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
    Waldron-Lynch F; Herold KC
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease prevention with islet autoantigens.
    Eisenbarth GS; Jasinski JM
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):59-73, viii. PubMed ID: 15053895
    [No Abstract]   [Full Text] [Related]  

  • 14. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.
    Graner MW; Bigner DD
    Expert Rev Anticancer Ther; 2006 May; 6(5):679-95. PubMed ID: 16759160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein-based cancer vaccines.
    Lee KP; Raez LE; Podack ER
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):637-59. PubMed ID: 16762728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune intervention with anti-CD3 in diabetes.
    Harlan DM; von Herrath M
    Nat Med; 2005 Jul; 11(7):716-8. PubMed ID: 16015359
    [No Abstract]   [Full Text] [Related]  

  • 19. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
    Shekhar C
    Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.